Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUGKISS: Hydroxyurea Management in Kids
NCT03020615Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by St. Jude Children's Research Hospital. Started May 2017; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03020615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020615.